当前位置: X-MOL 学术Bioorg. Med. Chem. Lett. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ.
Bioorganic & Medicinal Chemistry Letters ( IF 2.7 ) Pub Date : 2020-01-22 , DOI: 10.1016/j.bmcl.2020.126955
Michael C Myers 1 , Donna M Bilder 1 , Cullen L Cavallaro 1 , Hannguang J Chao 1 , Shun Su 1 , Neil T Burford 1 , Akbar Nayeem 1 , Tao Wang 1 , Mujing Yan 1 , Robert A Langish 1 , Marta Dabros 1 , Yi-Xin Li 1 , Anne V Rose 1 , Kamelia Behnia 1 , Joelle M Onorato 1 , Peter S Gargalovic 1 , Ruth R Wexler 1 , R Michael Lawrence 1
Affiliation  

This article describes the discovery of aryl hydroxy pyrimidinones and the medicinal chemistry efforts to optimize this chemotype for potent APJ agonism. APJ is a G-protein coupled receptor whose natural agonist peptide, apelin, displays hemodynamic improvement in the cardiac function of heart failure patients. A high throughput screen was undertaken to identify small molecule hits that could be optimized to mimic the apelin in vitro response. A potent and low molecular weight aryl hydroxy pyrimidinone analog 30 was identified through optimization of an HTS hit and medicinal chemistry efforts to improve its properties.

中文翻译:

发现和SAR芳基羟基嘧啶酮作为GPCR APJ的有效小分子激动剂。

本文介绍了芳基羟基嘧啶酮的发现以及为有效APJ激动优化这种化学型的药物化学努力。APJ是一种G蛋白偶联受体,其天然激动剂肽apelin在心力衰竭患者的心脏功能中显示出血液动力学改善。进行了高通量筛选,以鉴定可优化以模拟apelin体外反应的小分子命中。通过优化HTS命中和药物化学努力以改善其性能,鉴定出了有效的低分子量芳基羟基嘧啶酮类似物30。
更新日期:2020-01-22
down
wechat
bug